Stocktoria
SINOVAC BIOTECH LTD SVA
SINOVAC BIOTECH LTD (SVA) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the safe zone. It pays a dividend (safety: n/a).
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2014-03-20 | Morgan Stanley | Overweight (up) |
| 2013-11-13 | Aegis Capital | Buy (main) |
| 2013-08-15 | Aegis Capital | Buy (up) |
| 2013-05-15 | Morgan Stanley | Equal-Weight (up) |
| 2013-03-14 | Aegis Capital | Hold (main) |
| 2012-12-12 | Aegis Capital | Hold (init) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.647 |
| Retained earnings / assets | 0.33 |
| EBIT / assets | -0.057 |
| Equity / liabilities | 2.981 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| SVA | SINOVAC BIOTECH LTD | 3/9 | 8.06 | — | +6.8% |
| ARQT | Arcutis Biotherapeutics, Inc. | 4/9 | -3.68 | — | +91.3% |
| ESPR | Esperion Therapeutics, Inc. | 3/9 | -8.63 | — | +21.3% |
| ARDX | ARDELYX, INC. | 2/9 | -2.34 | — | +22.1% |
| INVA | Innoviva, Inc. | 3/9 | 6.59 | — | +14.7% |
| MNKD | MANNKIND CORP | 3/9 | -11.89 | 218.2 | +22.2% |
| ZLAB | Zai Lab Ltd | 3/9 | -3.61 | — | +15.3% |
FAQ
Is SVA financially healthy?
SINOVAC BIOTECH LTD's Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does SVA pay a dividend, and is it safe?
Yes. SINOVAC BIOTECH LTD pays a dividend with a None payout ratio, rated “n/a” for safety.
What is the analyst price target for SVA?
The average Wall-Street price target for SINOVAC BIOTECH LTD is $3.52, from 6 analysts (consensus: buy).
Is SVA a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on SINOVAC BIOTECH LTD: a Piotroski F-score of 3/9, an Altman Z″ in the safe zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.